On Tuesday, Oncology Institute Inc (NASDAQ: TOI) opened lower -1.54% from the last session, before settling in for the closing price of $3.25. Price fluctuations for TOI have ranged from $0.13 to $3.50 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 46.48% at the time writing. With a float of $38.73 million, this company’s outstanding shares have now reached $88.93 million.
Let’s determine the extent of company efficiency that accounts for 825 employees. In terms of profitability, gross margin is 10.42%, operating margin of -12.91%, and the pretax margin is -15.96%.
Oncology Institute Inc (TOI) Insider Activity
A key investor’s attitude towards the stock of the Medical Care Facilities industry is another important factor to consider. The insider ownership of Oncology Institute Inc is 56.57%, while institutional ownership is 15.18%. The most recent insider transaction that took place on Jun 03 ’25, was worth 113,652. Before that another transaction happened on Jun 03 ’25, when Company’s Director proposed sale 1,936,537 for $2.87, making the entire transaction worth $5,557,861.
Oncology Institute Inc (TOI) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 46.48% per share during the next fiscal year.
Oncology Institute Inc (NASDAQ: TOI) Trading Performance Indicators
Check out the current performance indicators for Oncology Institute Inc (TOI). In the past quarter, the stock posted a quick ratio of 1.59. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.71.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.70, a number that is poised to hit -0.09 in the next quarter and is forecasted to reach -0.09 in one year’s time.
Technical Analysis of Oncology Institute Inc (TOI)
Looking closely at Oncology Institute Inc (NASDAQ: TOI), its last 5-days average volume was 2.48 million, which is a jump from its year-to-date volume of 1.16 million. As of the previous 9 days, the stock’s Stochastic %D was 77.75%. Additionally, its Average True Range was 0.37.
During the past 100 days, Oncology Institute Inc’s (TOI) raw stochastic average was set at 90.76%, which indicates a significant increase from 76.42% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 132.98% in the past 14 days, which was lower than the 138.90% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.35, while its 200-day Moving Average is $0.92. However, in the short run, Oncology Institute Inc’s stock first resistance to watch stands at $3.34. Second resistance stands at $3.47. The third major resistance level sits at $3.71. If the price goes on to break the first support level at $2.97, it is likely to go to the next support level at $2.73. Should the price break the second support level, the third support level stands at $2.60.
Oncology Institute Inc (NASDAQ: TOI) Key Stats
There are currently 89,234K shares outstanding in the company with a market cap of 285.42 million. Presently, the company’s annual sales total 393,410 K according to its annual income of -64,660 K. Last quarter, the company’s sales amounted to 104,410 K and its income totaled -19,590 K.
